Mirae Asset Global Investments’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Buy |
6,465
+884
| +16% | +$19.1K | ﹤0.01% | 1094 |
|
|
2025
Q1 | $95.3K | Buy |
5,581
+36
| +0.6% | +$615 | ﹤0.01% | 1135 |
|
|
2024
Q4 | $94K | Sell |
5,545
-454
| -8% | -$7.7K | ﹤0.01% | 1160 |
|
|
2024
Q3 | $94.1K | Buy |
5,999
+1,066
| +22% | +$16.7K | ﹤0.01% | 1191 |
|
|
2024
Q2 | $80.8K | Sell |
4,933
-71,859
| -94% | -$1.18M | ﹤0.01% | 1169 |
|
|
2024
Q1 | $1.42M | Sell |
76,792
-8,988
| -10% | -$166K | ﹤0.01% | 1358 |
|
|
2023
Q4 | $2.69M | Buy |
85,780
+4,442
| +5% | +$139K | 0.01% | 1129 |
|
|
2023
Q3 | $1.7M | Buy |
81,338
+6,519
| +9% | +$136K | ﹤0.01% | 1250 |
|
|
2023
Q2 | $1.79M | Sell |
74,819
-1,854
| -2% | -$44.4K | ﹤0.01% | 1268 |
|
|
2023
Q1 | $1.44M | Buy |
76,673
+15,920
| +26% | +$300K | ﹤0.01% | 1356 |
|
|
2022
Q4 | $967K | Buy |
60,753
+844
| +1% | +$13.4K | ﹤0.01% | 1517 |
|
|
2022
Q3 | $980K | Buy |
59,909
+14,032
| +31% | +$230K | ﹤0.01% | 1493 |
|
|
2022
Q2 | $646K | Buy |
45,877
+33,924
| +284% | +$478K | ﹤0.01% | 1627 |
|
|
2022
Q1 | $289K | Sell |
11,953
-476
| -4% | -$11.5K | ﹤0.01% | 1515 |
|
|
2021
Q4 | $290K | Buy |
12,429
+139
| +1% | +$3.24K | ﹤0.01% | 1500 |
|
|
2021
Q3 | $204K | Buy |
12,290
+1,750
| +17% | +$29K | ﹤0.01% | 1687 |
|
|
2021
Q2 | $258K | Buy |
+10,540
| New | +$258K | ﹤0.01% | 1606 |
|
|
2021
Q1 | – | Sell |
-8,418
| Closed | -$450K | – | 1524 |
|
|
2020
Q4 | $450K | Buy |
8,418
+332
| +4% | +$17.7K | ﹤0.01% | 1346 |
|
|
2020
Q3 | $333K | Buy |
8,086
+808
| +11% | +$33.3K | ﹤0.01% | 1315 |
|
|
2020
Q2 | $352K | Buy |
+7,278
| New | +$352K | ﹤0.01% | 1267 |
|